 |
|
Understanding the Mechanism of Action and Clinical Implications of Anti-Obesity Drugs Recently Approved in Korea
Kyoung Kon Kim
Korean J Fam Med. 2019;40(2):63-71. Published online 2019 Mar 20 DOI: https://doi.org/10.4082/kjfm.19.0013
|
|
Citations to this article as recorded by
 Comparison of the Efficacy of Anti-Obesity Medications in Real-World Practice
Ji-Eun Song, Hae-Jin Ko, A-Sol Kim
Drug Design, Development and Therapy.2024; Volume 18: 845. CrossRef 360-Degree Perspectives on Obesity
Magdalena Cuciureanu, Cătălin-Cezar Caratașu, Levon Gabrielian, Otilia Elena Frăsinariu, Laura Elisabeta Checheriță, Laura Mihaela Trandafir, Gabriela Dumitrița Stanciu, Andrei Szilagyi, Ina Pogonea, Gabriela Bordeianu, Radu Petru Soroceanu, Călin Vasile
Medicina.2023; 59(6): 1119. CrossRef Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options
Arturo Cesaro, Gianantonio De Michele, Fabio Fimiani, Vincenzo Acerbo, Gianmaria Scherillo, Giovanni Signore, Francesco Paolo Rotolo, Francesco Scialla, Giuseppe Raucci, Domenico Panico, Felice Gragnano, Elisabetta Moscarella, Olga Scudiero, Cristina Menn
Frontiers in Cardiovascular Medicine.2023;[Epub] CrossRef AgRP/NPY and POMC neurons in the arcuate nucleus and their potential role in treatment of obesity
Muhammad Sufyan Vohra, Khaled Benchoula, Christopher J. Serpell, Wong Eng Hwa
European Journal of Pharmacology.2022; 915: 174611. CrossRef Efficacy of subcutaneous semaglutide compared to placebo for weight loss in obese, non-diabetic adults: a systematic review & meta-analysis
Naazneen Arastu, Olivia Cummins, Wanda Uribe, Eric C. Nemec
International Journal of Clinical Pharmacy.2022; 44(4): 852. CrossRef Pharmacotherapy in obesity: the current state and the near future
Yoon Jeong Cho, Kyoung-Kon Kim
Journal of the Korean Medical Association.2022; 65(8): 514. CrossRef FDA-Approved Pharmacotherapy for Weight Loss Over the Last Decade
Zarwa Idrees, Ivan Cancarevic, Li Huang
Cureus.2022;[Epub] CrossRef Computational Drug Repurposing Approach to Identify Potential Fatty Acid-Binding Protein-4 Inhibitors to Develop Novel Antiobesity Therapy
Somdutt Mujwar, Vivek Kumar
ASSAY and Drug Development Technologies.2020; 18(7): 318. CrossRef Managing obesity through natural polyphenols: A review
Manisha Singh, Thilini Thrimawithana, Ravi Shukla, Benu Adhikari
Future Foods.2020; 1-2: 100002. CrossRef Reducing Effect of Farnesylquinone on Lipid Mass in C. elegans by Modulating Lipid Metabolism
Xihua Jia, Manglin Xu, Aigang Yang, Yan Zhao, Dong Liu, Jian Huang, Peter Proksch, Wenhan Lin
Marine Drugs.2019; 17(6): 336. CrossRef Mechanisms of action and clinical applications of anti-obesity drugs currently available in Korea
Kyoung Kon Kim
Journal of the Korean Medical Association.2019; 62(11): 588. CrossRef
|